Stealth BioTherapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
140 Kendrick St, Needham, Massachusetts,...Phone Number
(617) 600-6888Website
www.stealthbt.comRevenue
$28.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Established in 2006, Stealth BioTherapeutics is headquartered in Newton, Massachusetts, United States.Explore more
Stealth BioTherapeutics Org Chart
AH
Chief Scientific Officer. Head of Regulatory ...
AS
Chief Scientific Officer
SB
Chief Scientific Officer
JG
Chief Scientific Officer and Co-Founder
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stealth BioTherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Stealth BioTherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Stealth BioTherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Stealth BioTherapeutics launches new products
Earning: See what the market has to say on Stealth BioTherapeutics recently announced quarterly report
Click to see if Stealth BioTherapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Stealth BioTherapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Stealth BioTherapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Stealth BioTherapeutics
Recommended Actions
Reach out to Masked Content who joined Stealth BioTherapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Stealth BioTherapeutics
Compare insights from companies similar to Stealth BioTherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Public
$340.3M
2005
MA
Melissa AshlockVice President, External Scientific Alliances & Human Genetics
Company Profile Activity
Activity Insights
Stealth BioTherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stealth BioTherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stealth BioTherapeutics.
Stealth BioTherapeutics financials insights
Gather financial insights about Stealth BioTherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Private Equity
$30M
Debt
$25M
2022
Private Equity
$3.5M
Stealth BioTherapeutics Tech Stack
A closer look at the technologies used by Stealth BioTherapeutics
See more technologies
Most Recent Scoops
Person-Based
Product Development, Corporate Strategy
Person-Based
Events
Person-Based
Medical Research
Person-Based
Events
Project
Laboratory Operations, Medical Research, Clinical Operations
Stealth BioTherapeutics News & Media
Stealth BioTherapeutics to Present Updates on Elamipretide in Barth Syndrome and POLG Disease at Euromit 2026
– Design of Confirmatory Study in Barth Syndrome to Be Presented – – Phase 3 NuPOWER Results Support Development of Elamipretide in POLG1 Subgroup – NEEDHAM, Mass., May 26, 2026 /PRNewswire/ -- Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company...Stealth BioTherapeutics to Present Clinical Data for Bevemipretide Eye Drops at the Association for Research in Vision and Ophthalmology 2026 Annual Meeting
– Data from Phase 1 dose escalation trial will inform planned Phase 2 trial for dry AMD – NEEDHAM, Mass., April 27, 2026 /PRNewswire/ -- Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development, and...Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company's Pioneering Work in Mitochondrial Medicine
– Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership – – Appointment signals expansion of executive team to support a growing proprietary pipeline in rare and age-related diseases of mitochondrial dysfunction – NEEDHAM, Mass., April 8,...Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research
-- Award to support the Company's preclinical evaluation of SBT-589 in Leigh syndrome -- NEEDHAM, Mass. and HARWELL, England, March 23, 2026 /PRNewswire/ -- Stealth BioTherapeutics (the "Company"), a commercial-stage biotechnology company focused on the discovery, development, and...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stealth BioTherapeutics
Sign Up For FreeTo access detailed company insights
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Established in 2006, Stealth BioTherapeutics is headquartered in Newton, Massachusetts, United States.... Read More
